Rhumbline Advisers »

First Tracks Biotherapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $632k 31k 20.12

More positions owned by Rhumbline Advisers

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Micron Technology (MU)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Visa (V)

View all positions for Rhumbline Advisers

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics